# Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder

> **NCT01878292** · PHASE3 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 529 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Placebo
- **DRUG:** Vilazodone
- **DRUG:** Vilazodone

## Key facts

- **NCT ID:** NCT01878292
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07-11
- **Primary completion:** 2016-03-17
- **Final completion:** 2016-10-05
- **Target enrollment:** 529 (ACTUAL)
- **Last updated:** 2019-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01878292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01878292, "Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01878292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*